Indefinite Delivery Contract SPE2DR25D9978

The subject federal contract IDV is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999 and valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The original solicitation, issued under the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V, aims to establish multiple regional prime vendor contracts worth an estimated $30.3 billion to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The contracts will have a 30-month base period and three 30-month option periods, and awards will be made on a regional basis with the intent to have at least three different contractors to ensure supply chain resiliency. The solicitation is expected to be issued in March 2024 and will be a Lowest Price Technically Acceptable (LPTA) acquisition.